Status:
UNKNOWN
Protocol-driven Hemodynamic Support for Patients With Septic Shock
Lead Sponsor:
National Institute of General Medical Sciences (NIGMS)
Conditions:
Shock, Septic
Severe Sepsis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research is being done to see if a protocol (a set of orders that determine how much and how quickly a drug/fluid is given) for fluid and drugs used to increase blood pressure (vasopressors) will...
Detailed Description
Septic shock is low blood pressure caused by an infection. Sepsis is the most common cause of death in non-cardiac intensive care units, and septic shock is the most severe form of sepsis. Treatment f...
Eligibility Criteria
Inclusion
- ACCP/SCCM sepsis criteria
- Need for institution of vasopressors after adequate volume resuscitation
Exclusion
- Age\< 18
- On vasopressors for \> 24 hours prior to ICU admission
- Other cause for shock ( cardiac tamponade, massive pulmonary embolus, cardiogenic shock)
- Physicians and family not committed to aggressive medical therapy ( a patient will not be excluded if he/she would receive all care except for attempts at resuscitation from cardiac arrest)
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2011
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00335907
Start Date
September 1 2006
End Date
January 1 2011
Last Update
August 25 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, United States, 21224